Early Outcomes of a National Cancer Center's Strategy Against COVID-19 Executed Through a Disease Outbreak Response Taskforce.
Jin Wei KwekJack J ChanRavindran KanesvaranMichael L C WangPatricia S H NeoClaramae S ChiaChee Kian ThamLita S T ChewHiang Khoon TanSwee Peng YapRebecca A DentWilliam Y K HwangSoon Thye LimPublished in: JCO oncology practice (2021)
Through the coordinated efforts of a DORS taskforce, it is possible to avoid nosocomial SARS-CoV-2 transmissions among patients and staff without compromising on care delivery at a national cancer center.
Keyphrases
- sars cov
- quality improvement
- respiratory syndrome coronavirus
- coronavirus disease
- healthcare
- palliative care
- acinetobacter baumannii
- type diabetes
- escherichia coli
- methicillin resistant staphylococcus aureus
- skeletal muscle
- metabolic syndrome
- affordable care act
- drug resistant
- insulin resistance
- klebsiella pneumoniae
- staphylococcus aureus
- cystic fibrosis
- glycemic control